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Abstract
Drugs of abuse, including alcohol and stimulants like cocaine, produce effects that are
subject to individual variability, and genetic variation accounts for at least a portion of
those differences. Notably, research in both animal models and human subjects point
towards reward sensitivity and impulsivity as being trait characteristics that predict
relatively greater positive subjective responses to stimulant drugs. Unfortunately, past
efforts have yet to yield convincing insights into underlying genetic influences on these
traits due to the characteristics of the mouse panels used. The Collaborative Cross (CC)
recombinant inbred mouse strains, their inbred founders, and the Diversity Outbred (DO)
mice that are derived from them are a powerful genetic reference panel that has potential
as a tool for revealing genetic contributions to cocaine abuse and related traits. Here we
describe use of the eight CC/DO founder strains to examine the heritability of reward
sensitivity and impulsivity traits, as well as genetic correlations between these measures
and existing addiction-related phenotypes. Methods. Founder strains were all tested for
activity in an open field and reward sensitivity (intake of chocolate BOOST®). Mice
were then divided into two counterbalanced groups and underwent reversal learning
(impulsive action) or delay discounting (impulsive choice). Results. The founder mice
demonstrate significant heritability for anticipatory responding within the reversal task,
k-value within delay discounting, locomotor activity, and reward sensitivity. Total trials
to criteria within reversal was positively correlated with ethanol intake in female mice.
This research was conducted within the broader, inter-laboratory effort of the Center for
Systems Neurogenetics of Addiction (CSNA) to characterize CC and DO mice for
multiple, cocaine abuse related traits. These data will facilitate the discovery of genetic
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correlations between predictive traits, which will then guide discovery of genes and
genetic variants that contribute to addictive behaviors.
Funding: These studies were supported, in part, by Public Health Service grants P50DA041602 and T32-AA025606.
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Heritable variation in reward sensitivity and impulsive action and choice in a genetically
diverse inbred mouse panel
Not all those who initiate drug or alcohol use will progress to a pathological state,
in which the user sustains personal damage and struggles to reduce or cease use. It has
been proposed that progression of drug seeking to drug addiction follows a multistep
process: recreational and/or sporadic drug use, intensified and sustained drug use, and
ultimately an uncontrolled substance use disorder (SUD) (Piazza & Deroche-Gamonet,
2013). Transition from recreational use to sustained use is often a shift in quantity of the
drug taken, while transition from sustained use to loss of control is a shift in quality, with
users primarily exhibiting goal-directed drug taking behavior and exhibiting difficult with
limiting or confining drug taking (Piazza & Deroche-Gamonet, 2013). Monozygotic and
dizygotic twin studies have been essential in laying the foundation of quantifying
susceptibility. Evidence from twin studies supports the idea that the majority of risk for
developing an SUD relates to a single common genetic factor, as well as less potent
environmental influences (Kendler et al., 2003). An essential aim of current drug studies
must be to understand the fundamental differences between users who are at risk for
developing an SUD, and those who do not develop a pathological pattern of using.
Addiction criteria in these circumstances is defined by the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5, American Psychiatric
Association, 2013), which represents one effort to separate recreational drug use from
pathological forms of consumption. The DSM-5 lists eleven criteria that qualify an
individual for an SUD. Meeting 2-3 items is considered a mild SUD, 4-5 is moderate, and
6+ is severe. These criteria include factors such as taking the substance in larger amounts
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and for longer than intended, continued use despite attempting to stop, and tolerance and
withdrawal manifestation (American Psychiatric Association, 2013).
The simplest explanation for the initial development of drug use is that users like
and/or want the drug (Wise & Bozarth, 1987; Robinson & Berridge, 1993), which is
supported by physiological evidence. Drugs of abuse typically result in a great increase of
dopamine and a slow habituation in response to the drug (Piazza & Deroche-Gamonet,
2013), thereby increasing salience and conditioning the user to continue usage.
Recreational drug use is easily acquired in laboratory animals; conventional laboratory
animal models will, in many cases, learn to self-administer a subset of drugs with abuse
liability, and most humans use some form of drug with abuse liability (Piazza &
Deroche-Gamonet, 2013). Escalation of use is likely a combination of desiring the drug
and being unable to refrain, though this does not explain why some users are more
resistant, and only a minority become addicts.
This progression to loss of control and qualification for and SUD is influenced by
a myriad of genetic and environmental factors that interplay with drug consumption.
Narrowing down individual variability that is responsible for the progression to sustained
use requires the analysis of relevant variables. Multiple heritable phenotypes have been
shown to be predictive for heightened likelihood to seek out and use drugs in laboratory
animals, including locomotor response to novelty (Nadal, Armario, & Janak, 2002;
Piazza & Deroche-Gamonet, 2013), locomotor response to acute dose of drug (Piazza et
al., 1989), novelty preference (Belin et al., 2011; Molander et al., 2011), anxiety-related
behaviors (Spanagel et al., 1995), circadian phenotypes (Logan, Williams, & McClung,
2014; Rosenwasser, 2010), and impulsivity. These behaviors are not exclusive and likely
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have overlapping components, and by studying them in tandem can a better
understanding be gained of the biomarkers that lead to these drug-related phenotypes.
Defining and Assessing Impulsivity
Impulsivity is the trait-like proclivity to engage in excessive, uncontrolled, or rash
reward pursuit and consumption, called impulsive behaviors (Jentsch et al., 2014).
Impulses are not necessarily maladaptive or pathological, and can even be seen as
advantageous in evolutionary circumstances as they represent an organism’s desire to
obtain a highly salient reward (Jentsch et al., 2014). These behaviors can, however, be
considered pathological when they are intrusive, disrupt normal life routines, cause
clinical distress, or lead to harmful outcomes (Moeller et al., 2001). The DSM-5 includes
a category for Disruptive, Impulse-Control, and Conduct Disorders, which include
intermittent explosive disorder, pyromania, kleptomania, and conduct disorder.
Pathological impulsive behaviors are also a symptom of a variety of other psychiatric
disorders, including bipolar disorder, borderline personality disorder, suicide, and
substance use disorder. Thus, impulsivity is a phenotype of broad importance to many
diagnostic categories, including addictions. SUD features impaired control over
impulsive drug use (Jentsch et al., 2014) in symptoms defined by the DSM-5 such as:
1. Taking the drug in larger amounts and for longer than intended
2. Wanting to cut down or quit but not being able to do it
3. Spending a lot of time obtaining the drug
4. Craving or a strong desire to use the drug
8. Recurrent use of the drug in physically hazardous situations
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Impulsivity is also a defining factor in progressing through the stages of addiction,
between drug seeking, escalation, and uncontrolled use (Jentsch et al., 2014).
The assessment of impulsivity is similar between humans and animal models. In
human studies, impulsivity can be measured using self-report measures, which includes
the widely used Barratt Impulsiveness Scale (BIS-11), developed in 1959 and now in its
eleventh revision (Barratt, 1959). The BIS-11 is a 30 item self-report measure designed to
quantify three subtypes of impulsivity: cognitive impulsiveness, motor impulsiveness,
and non-planning impulsiveness. Participants rate each question from 1-4 depending on
how much they agree or disagree that it describes them (e.g. I make-up my mind
quickly). The BIS-11 has wide application and has been used to assess impulsivity in
populations of cocaine users, ecstasy users, mood disorders, suicide attempters, and
criminals, as well as been translated into 11 languages (Stanford et al., 2009). Behavioral
tasks have also been developed to quantify impulsive phenotypes in humans, such as the
Go/No-Go task, delay discounting, and the balloon analogue risk task, which have
analogs for use in animal models.
A common test of impulsivity, delay discounting, was initially created to assess
rats and pigeons (Evenden & Ryan, 1996), though is now used in both human and animal
subjects with variations to the methodology. Delay discounting is a paradigm established
to assess an individual’s tendency to reduce (discount) the subjective value of a reward if
it has to wait to receive it. Often high value rewards incorporating a delay are chosen less
than lower value rewards that can be received immediately (Ainslie, 1975). The delay
discounting procedure aims to establish how the subject therefore discounts the delayed
reward, either by altering the volume of reward or the length of delay. A fundamental
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aspect of delay discounting is that the subject’s responses during the delay procedure do
not affect the trial; that is, that the subject makes an action to choose either reward, and
then must wait for the consequence, thus differing from other similar procedures such as
the differential reinforcement task (Evenden, 1999), and measuring impulsive choice. In
analyzing delay discounting data, an equation is derived to match the curve relating delay
to subjective value and estimating a value called k, which represents the scaling factor of
a delay; the effect of the delay to reduce subjective value is larger among subjects with a
large k value, and smaller among subjects with a smaller k value (Odum, 2011).
Human and animal delay discounting studies have fundamental differences in
paying out. Delay discounting studies have been conducted in laboratory animals for
reinforcers such as food, liquids, and intravenous (IV) drug administration (Calvert,
Green, & Myerson, 2013), and the subject actually receives the reward after the trial.
Studies with human participants often use money as a reward incentive and follow the
Hyperbolic Delay-Discounting Model (Reynolds, 2006), which measures the devaluing
of a reward over increasing delay times. Hyperbolic delay discounting often incorporates
adjusting delay or adjusting amount to identify the subject’s indifference point: the
difference in size/value the delayed reward has to be in order to be chosen equally to the
immediate reward (Reynolds, 2006). Human delay discounting studies can be sorted into
three different categories: hypothetical, real reward, and real time (Reynolds, 2006).
Hypothetical experiments ask the subject to make choices between two rewards, one with
a delay (ex. Would you rather have $5 now or $15 in 10 days?), though the subject does
not actually experience the delay or the reward. Face validity is a concern in hypothetical
studies, and real reward studies therefore honor one random decision during the course of
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the experiment and pay out immediately or with the delay accordingly. Delay discounting
is often used in affected populations, such as individuals who engage in pathological drug
consumption, gambling, or overeating. Morbidly obese women showed greater delay
discounting than control women (Weller et al., 2008), and pathological gamblers showed
increased delay discounting compared to healthy controls (Alessi & Petry, 2003; Dixon,
Marley, & Jacobs, 2003).
Another popular test of impulsivity is reversal learning, which revolves around
changing reinforcement contingencies: an action (e.g. pressing a lever) is paired with an
outcome (e.g. receiving a food reward) so that the subject learns the actions necessary to
receive the reward, and then learn to discriminate between stimuli (e.g. only pressing the
left lever, not the right, leads to the food reward) (Izquierdo & Jentsch, 2011). After
reaching an accuracy criterion, the contingencies are reversed (e.g. only pressing the right
lever, not the left, now leads to the food reward). Subjects must demonstrate cognitive
and behavioral flexibility, or impulse control, by constraining their previous responses
and discarding the initially learned rule. Greater difficulty with stopping or updating
behavior during reversal learning has been suggested to reflect greater impulsive action.
Studies have shown that this behavioral inflexibility is genetically linked to impulsivity
(Franken et al., 2008; Izquierdo & Jentsch, 2011). Reversal learning is impaired in OFClesioned animals (Boulougouris, Dalley, & Robbins, 2007) and in humans with relatively
low striatal baseline dopamine synthesis capacity (Cools et al., 2009).
The Five-Choice Serial Reaction Time Task (5-CSRTT) was initially developed
to reflect the Connor’s performance test, measuring attention and executive control in
children with ADHD (Robbins, 2002), though has since been adapted for animal models.
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The animal is presented with five horizontally arranged nose-poke holes, one of which
briefly illuminates, and must make a response in the correct (illuminated) hole. Accuracy
is regarded as a measure of attention capacity, and anticipatory responding (making a
nose poke before the visual signal is delivered) is considered as a failure in impulse
control (Bari, Dalley, & Robbins, 2008). Anticipatory responses are considered to be
waiting impulsivity, or the inability to withhold response in anticipation of a rewardrelated cue (Dalley, Everitt, & Robbins, 2011). Due to the nature of the 5-CSRTT, it is
said to have overlap with delay discounting, which also measures willingness to wait for
a reward (Dalley, Everitt, & Robbins, 2011).
The Multidimensional Model of Impulsivity
These tests of impulsivity described above, as well as others, are thought to be
measuring different facets of impulsivity. Evenden (1999) proposed the multidimensional
model of impulsivity, stating that the concept of impulsivity covered a wide range of
behaviors and was difficult to define precisely. He published multiple studies that used
three tasks measuring conceptually different types of impulsivity: visual discrimination
(preparation to respond), the fixed consecutive number schedule (FCN; behavior
execution), and variable delay of reinforcement (assessment of outcome). Visual
discrimination aims to test reflection impulsivity (Kagan, 1966), or the tendency to either
deliberate (reflect before responding) or act without deliberation in situations of
uncertainty. The FCN, like the 5-CSRT, measures waiting impulsivity by counting
anticipatory responses made before the mandatory number of lever presses to receive a
reward. The variable delay of reinforcement is similar to delay discounting in that it asks
rats to choose between one pellet immediately or several pellets after a delay.
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Rats in these studies were treated with amphetamine, haloperidol, imipramine,
citalopram, 8-OH-DPAT, DOI, WAY-100635, or ritanserin, and subsequent behavioral
effects (decreasing the impulsive behavior, increasing the impulsive behavior, or having
no effect) were measured. A single drug did not have the same effect on each test; for
example, ethanol had no effect on the unreliable visual discrimination or FCN, but
increased impulsive behavior of the variable delay of reinforcement (Evenden, 1999).
Some drugs even had opposing effects; for example, haloperidol was found to decrease
impulsive behavior in the unreliable visual discrimination task but increase impulsive
behavior on the FCN, while having no behavioral effect on the variable delay of
reinforcement (Evenden, 1998). Therefore Evenden concluded that there were different
facets of impulsivity, each having a unique set of pharmacological influences. Evenden
provided examples of different types of impulsivity, including response inhibition,
resistance to delay of reinforcement, timing, behavioral switching, motor impulsivity,
cognitive impulsivity, preparation, execution outcome, premature responding, and lack of
persistence. Evenden did, however, conclude that this research had its limitations. There
could have been confounding factors such as only one procedure was used to measure
each proposed type of impulsivity, as well as the impulsivity score changing without
there being a true change in impulse control, such as how ethanol exposed rats would
inexplicably choose the immediate lever repeatedly over the delayed lever, despite the
delay being 0s. Evenden expressed that this is an example of a way behavior can be
altered without impulsivity changing, perhaps due to drug side effects.
Evenden’s research has been replicated since, and the multidimensional theory of
impulsivity remains a popular one. For example, a study found that rats who had
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forebrain levels of 5-HT depleted with 5,7-dihydroxytrytamine had increased premature
responding in a 5-choice serial reaction time task and enhanced locomotor activity in
response to conditioned food presentation, though no difference in impulsive choice
behavior in delay discounting (Winstanley et al., 2004). No significant bivariate
correlation between impulsive action (five-choice serial reaction time task) and impulsive
choice (delay discounting) has been found in either lab rats or humans, and furthermore,
in humans three factors reflecting statistically orthogonal measures of impulsivity were
identified: self-report, impulsive action, and impulsive choice (Broos et al., 2012). One
study of human pathological gamblers revealed impaired behavior on impulsive action
(stop-signal task) but not impulsive choice (delay discounting) (Brevers et al., 2012),
though separate studies have found increases in impulsive choice in pathological
gamblers (Alessi & Petry, 2003; Dixon, Marley, & Jacobs, 2003). These findings may be
attributed to different areas of the brain regulating each type of impulsivity. In rats,
impulsive action was associated with reduced dopamine release in the nucleus accumbens
core, while impulsive choice was associated with reduced dopamine release in the
nucleus accumbens core, shell, and medial prefrontal cortex (Diergaarde et al., 2008). In
rats again, lesions of the subthalamic nucleus increased impulsive action, though
decreased impulsive choice (Uslaner & Robinson, 2006).
Despite proposed differences in the types of impulsivity, there is evidence for
these facets being linked to similar underlying neural mechanisms in frontostriatal
circuitry. Examining the neurological components of impulse control reveals that
dopamine plays a heavy role in controlling impulsivity, even taking into consideration the
different types. Blocking dorsomedial striatal dopamine D2-like receptors impairs
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response inhibition in the stop signal task, while blocking D1-like receptors improves it
(Eagle et al., 2011). This result is mirrored for waiting as well, as activating D1-like
receptors in the medial prefrontal cortex results in reduced anticipatory responding in the
five-choice serial reaction time task (Chudasama & Robbins, 2004). This similar
underlying circuitry challenges the distinction of subgroups of impulsivity and the
supposed strong categorical differences, imploring further research to empirically test the
relationship between the conceptually distinct facets. Jentsch et al. (2014) postulated two
theories on impulsivity’s relationship to drug abuse. The first theory states that the forms
of impulsivity share some mechanisms with one another but that they each relate to and
predict addiction vulnerability through a set of distinct, unique biological mechanisms
and pathways. The second theory states that the facets of impulsivity share a portion of
mechanism with each other and that this common biology is what links them all to
addiction. These common neural mechanisms may include relatively low D2 availability,
orbital and ventromedial frontal cortical dysfunction, and/or altered serotonergic
transmission.
Impulsivity and Drug Use
Regardless of the measure of impulsivity being evaluated, studies have identified
a strong and reproducible connection between substance use and impulsivity in humans,
specifically that impulsivity levels are both a predictor and outcome of substance use. A
review by de Wit (2008) reported that greater delay discounting has been seen in opioid
users (Kirby, Petry, & Bickel, 1999), cocaine users (Coffey et al., 2003), alcohol abusers,
and cigarette smokers (Bickel, Odum, & Madden, 1999). Heroin users undergoing
withdrawal had an increase in delay discounting for heroin and money (Giordano et al.,
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2002), while abstinent cigarette smokers only showed greater discounting for cigarettes
versus money (Field et al., 2006). Cocaine use severity correlated with gray matter
volume and reversal learning deficits in a cocaine-dependent population (Moreno-López
et al., 2014) and smokers showed greater activation of the ventrolateral prefrontal cortex
during monetary loss in the reversal task compared to healthy controls (de Ruiter et al.,
2009). Voon and colleagues (2014) developed a human analogue of the 5-CSRTT.
Subjects had to hold down the spacebar on a touch screen when four boxes appeared, and
after a specified period, a green circle appeared briefly in one of the boxes that the
subject would then have to touch after releasing the space bar. Anticipatory responding
was measured by the subject releasing the space bar before the target appeared. Alcohol,
methamphetamine, and cannabis users showed greater anticipatory responding compared
to healthy subjects, and smokers showed greater anticipatory responding compared to exsmokers and nonsmokers (Voon et al., 2014). Taken altogether, this research
demonstrates that either impulsivity is a predictor of drug use or an outcome.
Studies using animal models have mimicked the relationship found in human
participants, and animal subjects who had experienced various forms of exposure to
drugs or alcohol were found to be more impulsive than controls. Krueger and colleagues
(2009) injected mice daily with either cocaine or saline, waited two weeks, and then
assessed them on reversal learning, three-choice serial reaction time task, and a delayed
matching-to-position task, and found that cocaine-exposed mice had impairments in
reversal learning and working memory. Similarly it was found that rats treated by an
escalating dose of methamphetamine over four weeks and rats that received four weeks
of saline with a single dose of methamphetamine showed impaired reversal learning as
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compared to drug naïve rats (Kosheleff et al., 2012). In addition, chronic cocaine
exposure caused reversal learning deficits in monkeys (Jentsch et al., 2002). Combined
with human findings, a causal relationship has emerged with drug use resulting in high
impulsivity across a variety of impulsivity-measuring tasks.
Animal models are more rigorously able to probe the consequence-outcome
relationship of impulsivity and substance use better, and findings have indicated that
highly impulsive subjects have a greater susceptibility for drug or alcohol seeking and
consumption. Studies have shown that animal models that exhibit higher baseline
impulsivity have increased sensitivity to intravenous (IV) drug self-administration, as
well as acquisition and of instrumental IV drug self-administration (Jentsch et al., 2014).
Rats identified as highly impulsive by the five-choice serial reaction time task have
decreased D2/3 receptor availability and administer more cocaine (Dalley et al., 2007). In
a separate study, highly impulsive rats identified by adjusting delay acquired selfadministration faster, and females showed greater reinstatement at the highest dose
(Perry, Nelson, Carroll, 2008), and impulsive rats identified by delay discounting
displayed inelastic nicotine demand with consumption less sensitive to price increments
(Diergaarde et al., 2012). Belin et. al (2008) demonstrated that high impulsivity can
predict the switch to compulsive cocaine-taking, as more impulsive rats showed greater
persistent and drug-taking in the face of adversity. A study using the recombinant inbred
BxD mouse panel identified two strains as good reversal learners (good impulse control)
and two strains as poor reversal learners (poor impulse control), and found that the poor
reversal learning strains more rapidly acquired cocaine self-administration and administer
cocaine at greater rates (Cervantes, Laughlin & Jentsch, 2013).
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The Role of the Orbitofrontal Cortex
Studies have also demonstrated that the orbitofrontal cortex (OFC) and its outputs
to the basal ganglia, are key mechanisms for impulse control. The OFC has been
implicated in decision-making processes (Mar et al., 2011). It is further subdivided into
lateral and medial regions that are cytoarchitecturally distinct and have different
connections. The lateral region receives taste inputs and the medial region receives
olfactory inputs, while both receive visual and somatosensory inputs, as well as
projections from the amygdala and the mediodorsal thalamus (Elliot, Dolan, & Frith,
2000). The OFC is thus implicated as an area of convergence, which then projects to
crucial areas such as the medial temporal cortical areas, hypothalamus, brain stem, and
amygdala (Rempel-Clower, 2007). The OFC is able to target the intercalated nuclei of the
amygdala to provide inhibitory influences (Rempel-Cower, 2007).
The medial and lateral regions of the OFC have been implicated in controlling
different aspects of impulsive behavior. Primate studies have indicated that the medial
OFC is associated with monitoring reinforcement contingencies and adjusting responses
to varying incentive value of stimuli, and the lateral OFC is associated with punishment
and suppression of responses (Kringelback & Rolls, 2004; Mar et al., 2011). Mimicking
previous non-human primate findings, in a study using humans with frontal lobe legions,
it was found that those with lateral damage had impaired credit assessment, and those
with medial damage were more distracted by irrelevant options (Noonan et al., 2017).
Rats with lesions to the medial OFC showed increased preference for larger-delayed
reward and increased reversal learning, whereas rats with lesions to the lateral OFC
showed decreased preference and retarded reversal learning (Mar et al., 2011), and
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decreased dopamine transporter function in the OFC was associated with high impulsive
action in rats in the delay discounting task (Yates et al., 2016).
Disruptions in OFC function and dopaminergic transmissions lead to
susceptibility for drug self-administration and differences in addiction-related
phenotypes, such as impulsivity. Chronic drug exposure leads to epigenetic changes in
genes or their protein products, resulting in behavioral alteration such as heightened
impulsivity (Kreek et al., 2005), though animal studies have also demonstrated that
subjects can have a genetic predisposition for drug dependence.
Genetic Reference Populations
Genetic variation is an underlying mechanism associated with inter-individual
variation in impulse control, and in turn, addiction liability. The complexity of
impulsivity’s relationship with frontostriatal circuitry and drug abuse is best viewed
through an empirical lens of being able to quantify this liability. Thus far, there have been
few studies that focus on genetic evidence of these traits, due in large part to the qualities
of the reference panels used. Genetic reference populations (GRP) are sets of inbred
strains derived from common founders with known, replicable genomes (Iraqi et al.,
2011) that are a powerful resource for the study of complex phenotypes and genotyping.
Mouse GRPs are typically recombinant inbred (RI) mouse strains that can be used to
analyze heritable phenotypes, circumventing limitations from human studies. Genotyped
strains in particular permit identification of quantitative trait loci (QTL) and association
with the genes of interest, thus capable of validating underlying genes responsible for
human disorders (Iraqi et al., 2011). RI lines are produced by crossing two inbred strains
together to create a F2 lineage, and then crossing that lineage via sibling mating to
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produce genetically identical strains until approximately F22 (Broman, 2005). Existing
RI panels are often derived from just two inbred strains and thus lack genetic diversity
(Chesler et al., 2008), and panels such as the BxD have suffered from genetic drift
(Chesler, 2014).
First proposed at the Edinburgh meeting of the International Mouse Genome
Conference in October of 2001, the Collaborative Cross is a multi-parental RI panel. It
avoids genetic bottleneck limitations by using five classical inbred strains (A/J,
C57BL/6J, 129S1/SvImJ, NOD/LtJ, NZO/HlLtJ) as well as three wild inbred strains
(CAST/EiJ, PWK/PhJ, WSB/EiJ) to capture >90% genetic variation of lab mice strains
(Odet et al., 2015). In addition to having high genetic diversity, the Collaborative Cross
also has balanced allele frequencies and evenly distributed recombination sites (Aylor et
al., 2011), with only chromosome 2 having overrepresentation of WSB/EiJ alleles and on
chromosome X having a deficit of lines with CAST/EiJ alleles (Iraqi et al., 2011). The
result of this is more statistical power and less spurious correlations, as well as the ability
to develop correlations between multiple laboratories all using the Collaborative Cross
mice as subjects. In addition to the Collaborative Cross, the eight founder strains were
again used to develop the Diversity Outbred (DO) panel, which has the same allelic
diversity as the CC strains and is a complementary resource for genetic mapping
(Svenson et al., 2012).
Inbred mouse panels such as the CC permit estimates of heritability, which is
operationally defined as the proportion of phenotypic variation that is explained by
genetics. In inbred lines, heritability is estimated as the percent of phenotypic variance
account for by strain. Past genetic reference population studies have considered this to be
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an effective estimate of heritability, considering each mouse from each strain is, to the
extent maximally possible, genetically identical to one another (Philip et al., 2009).
Environmental and technical sources of variance are reduced within these panels, further
increasing the ability to detect heritability of a trait over external influence and providing
an advantage over human twin studies (Williams et al., 2004). The mathematical
definition of heritability is the strain intra-class correlation (Philip et al., 2009):
h2 = σ2Between Strain / (σ2Within Strain + σ2Between Strain)
Present Study
The present study aims to examine genetic correlations of reinforcement learning,
two tests of impulsivity (delay discounting and reversal learning), ethanol intake, and
other catalogued addiction-related behaviors measured by others in the eight CC/DO
founder strains. The tests of impulsivity are designed to measure three types of
impulsivity: impulsive action (total trials to criteria in reversal learning), impulsive
choice (k-value in delay discounting), and waiting impulsivity (anticipatory responses in
reversal learning). We except to find some statistical evidence that the three measures of
impulsivity are positively correlated with one another: if a strain rates high on impulsivity
in one paradigm, it will rate high on impulsivity in the other paradigms. We also
hypothesize that all tests of impulsivity will positively correlate with ethanol intake,
which would support the concept that different types of impulsivity predict liability to
exhibit escalated drug/alcohol intake. Phenotyping the founder strains will permit
heritability analyses of these measures, as well as allow correlations to be run on other
behavioral and biological phenotypes being studied in collaborating labs using the CC.
Results from this study will additionally provide insight into the correlation between the
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different types of impulsivity tested, and how they relate to ethanol intake, whether
uniquely or similarly.
Methods
Mice
The study utilized the eight CC/DO founder mouse strains (A/J, Stock No.
000646 [n=18]; C57BL/6J, Stock No. 000664 [n=18]; 129S1/SvImJ, Stock No. 002448
[n=18]; NOD/ShiLtJ, Stock No. 001976 [n=18]; NZO/H1LtJ, Stock No. 002105 [n=18];
CAST/EiJ, Stock No. 000928 [n=18]; PWK/PhJ, Stock No. 003715 [n=18] and WSB/EiJ,
Stock No. 001145 [n=18]). This study also includes two of the CC strains that are
recombinant inbred strains resulting from the 8-way intercross (CC041/TauUncJ Stock
No. 021893 [n=6], CC004/TauUncJ Stock No. 020944 [n=5]); these strains were selected
into this study because our collaborative group revealed that these strains exhibit
extremely different locomotor responses to cocaine, as well as different levels of cocaine
self-administration. Currently, this study has completed evaluation of a total of 155 mice
tested.
All animals were born at the Jackson Laboratory (Bar Harbor ME) and received
via overnight shipping to Binghamton University between 35-49 days of age. Founder
mice were delivered in three separate cohorts (N=48). Collaborative Cross mice were
first present in cohort three (N=12), with three male and three female mice of each strain
being represented in each cohort. All procedures involving animals were performed
according to the Guide for the Care and Use of Laboratory Animals (NIH) in the
AAALAC accredited program at Binghamton University with IACUC approval.
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Upon arrival, mice were socially-housed in the same groups in which they were
shipped, with three mice of the same strain and sex being grouped together in a cage.
Animals were housed in a colony room with a 12-h/12-h illumination cycle (lights on at
0615 h) at an average of 68°F. All mice had access to water ad libitum, except during
behavioral testing sessions (see below). At PND 60, mice were individually-housed in
identical caging conditions, due to the aggression of the CAST, WSB, and PWK strains
and the liability of injury when group-housed. They acclimated to the single house
conditions for 10 days until PND 70 and were undisturbed during this time, except for
weekly cage changes.
Upon receipt, and until PND 81, mice had ad libitum access to chow (Lab Diet
5001, ScottPharma Solutions), except during behavioral testing. All mice were then
introduced to limited access to food to facilitate operant conditioning. Mice were
weighed before food was removed, and that weight was recorded as their initial free
feeding weight. During the limited access to food period, mice were fed once a day in the
early afternoon, with non-wild mice initially receiving 3-g of chow per mouse and wildderived mice (WSB/EiJ, PWK/PhJ, and CAST/EiJ) initially receiving 4-g of chow. Mice
were weighed daily, and their weight was divided by their free feeding weight to obtain
their percentage change in body weight. Chow quantity provided per day was titrated
until mice reach 80-85% (non-wild) or 83-88% (wild-derived) of their free feeding
weights. Once mice were approximately 85% of their free feeding weight, operant testing
began (see Table 1 for mouse weights). If, at any point during the testing period, a mouse
dropped below 80% of their free feeding weight, their daily chow quantity was increased.
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If the mouse had two consecutive days being beneath 80%, they were temporarily
returned to ad libitum access to food until their weight had recovered.
Mice were handled by their tails, either with gloves (non-wild) or forceps (wildderived). During testing, all mice were removed from the operant box either by their tail
(non-wild) or by inserting the red tube from their home cage into the box, and removing
the tube when the mouse is inside (wild-derived).
Locomotor Response to Novelty and Habituation
At PND 70, mice were assessed for locomotor response in a novel open field
environment, during their light cycle. Mice were transported to a separate testing room on
a cart. Each mouse was individually placed in a 17 " L x 17" W x 12" H (43.2 x 43.2 x
30.5 cm) open field chamber fitted with infrared beams (Med-Associates MED-OFASRSU; St Albans VT). All open field chambers were within sound attenuating cubicles
measuring 26" W x 22" H x 20.5" D (66 x 52.7 x 55.9 cm) at the interior with walls 0.75"
(1.9 cm) thick. Activity was recorded for 40-min, divided into eight 5-minute bins. The
primary dependent measure examined here was total distance traveled in centimeters.
After the session, mice were immediately removed and returned to their home cage.
Apparati were cleaned with a mixture of 10% Alconox detergent in water. The next
group of mice was brought into the room and placed in the apparatus. This was repeated
until all groups had been tested.
The following day at the same time, the mice were placed back in the same open
field chamber, and activity parameters were again recorded for 40-min. In addition to
total distance traveled, the difference in total activity on day 2, compared with day 1, was
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also calculated (Day 2 – Day 1) to assess the degree of habituation of activity in the open
field environment.
Palatable Food Consumption
One day after the conclusion of locomotor assessments, mice received home cage
exposure to a highly palatable chocolate-flavored Boost solution (Nestle) from
approximately PND 72-73. Boost was made available in the home cage in a plastic petri
dish that was placed on top of the bedding. The solution was available continuously for
this 48-h period, with the solution being refreshed at the 24-h time point.
On PND 74-80, mice were evaluated for Boost (and water) consumption in 7,
consecutive, daily, 2-h lickometry sessions. All testing occurred during the light phase
and took place inside dual lickometer Scurry boxes (Model 80822S, activity wheel
removed; Lafayette Instruments). Each lickometer box is 35.3 x 23.5 x 20cm, and is fitted
with a food hopper and two 50mL sipper bottles. No food was provided during the
consumption test. One bottle was filled with Boost solution and the other was filled with
water; the position (left or right) of the two solutions relative to one another was
counterbalanced pseudorandomly across the testing days.
On testing days, mice were transported to the testing room on a cart. Room lights
were on during testing and a room dehumidifier provided ambient background noise. A
lickometer test was run prior to the mice being inserted to ensure that there were no
technical problems with the box (including leakage of the solutions). At that point, the
mice were placed, individually, into the lickometer boxes and were allowed to freely
consume Boost and water for a 2-h period. Licks on each spout (per second) were
counted by a computer. The number of licks was divided by the body weight of the
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animal to account for variability attributed to body weight differences. After the daily
sessions were completed, mice were transported back to the colony room and returned to
their home cages.
Operant Conditioning – Reversal Learning
As described above, mice were transitioned to a limited food access schedule,
once lickometer testing was completed. Once targeted reductions in body weights was
achieved, half of all the mice from each sex of each strain were randomly designated for
evaluation using an operant discrimination/reversal learning procedure. All operant
testing took place in 8.5" L x 7" W x 5" H (21.6 x 17.8 x 12.7 cm) operant modular
chambers (Model ENV-307W, Med Associates Inc.) with a stainless steel grid floor
(Model ENV-307W-GFW, Med Associates Inc.) and within a sound attenuating cubicle.
Mice were removed from their home cage by their tail and placed inside the operant box.
A box test program evaluating the function of the house light, white noise, five nose-poke
apertures, two response levers and reward delivery was conducted at the beginning of
each testing day.
Each mouse was sequentially tested in a series of programs; mice transitioned from
program to program individually, as they met criterion performance (see below). Mice
underwent the following programs:
Stage 1: Box habituation. House light and white noise were active. No
reinforcements were provided. The session lasted 1-h.
Stage 2: Magazine training. Again, the house light and white noise were active for
the duration of the test, and 20-21µl Boost is dispensed every 30 seconds. The session
ended after 1-h or after the mouse received 50 rewards, whichever came first.
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Stage 3: Initial operant conditioning. During this stage, mice are trained to insert their
nose into the center nose-poke aperture (hole 3 of 5). The session began with illumination
of the house light and activation of the white noise generator; 10-s later, aperture 3 of 5 is
illuminated (illumination of the hole was extinguished each time the mouse initiated a
response in this hole). A behavioral response that broke the photocell in the aperture
(usually, a nose poke) for at least 0, 100, or 200 msec (requirements varied from trial to
trial) was reinforced by the delivery of 20-21ul of Boost solution; after each reinforcer
was retrieved, a new trial was initiated 1.5-s later (signaled by illumination of the center
nose poke aperture). If a response was initiated but was not sustained for the 0, 100, or
200 msec period, a time out period of 2-s occurred, during which time the central nose
poke light and house light were extinguished. If a mouse did not voluntarily respond in
the center hole for at least 15 minutes, the center hole was baited with a Boost-saturated
cotton swab. Daily sessions lasted up to 1-h but were also terminated if an individual
mouse completed 50 schedules. Each mouse was tested daily on this stage until it
received at least 50 reinforcements in a single session, at which time it progressed to the
next stage.
Stage 4: In this second stage of operant conditioning, mice were tested under the
same basic conditions, except a minimum duration nose poke of 100- or 200-ms was
required to trigger reinforcement. If a mouse did not respond in the center illuminated
hole for 15 minutes, the center hole was baited with a Boost-saturated cotton swab. When
the mouse completed 50 schedules in a single session, it progressed to Stage 5.
Stage 5: In this third stage of operant conditioning, mice were tested under the same
basic conditions, except a minimum duration nose poke of 100-, 200-, or 300-ms was
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required to trigger reinforcement delivery. If a mouse did not respond in the center
illuminated hole for 15 minutes, the center hole was baited with a Boost-saturated cotton
swab. When the mouse completed 50 schedules in a single session, it progressed to Stage
5.
Stage 6: Discrimination learning stage. As above, session onset is signaled by
illumination of the house light and activation of the white noise generator; trial onset was
signaled by illumination of the center nose poke aperture. As in stage 5, mice first
completed an observing response into the center hole of 100-, or 200-ms duration. When
this occurred, the two apertures flanking the central hole (hole 2 and 4) were immediately
illuminated. A response into one of the two apertures (pseudorandomly assigned across
strains) resulted in the delivery of a Boost reinforcer. Poking into the other hole - or not
making any response within 30-s, triggered a time out, during which time the house light
was extinguished. Responses into the reinforced hole were counted as correct trials;
responses into the non-reinforced hole were counted as incorrect trials; and no response
after trial initiation was counted as an omission. Daily sessions of 1-hr were conducted
until learning criteria were met; this included a mouse completing at least 20 trials in a
single session, and at least 80% running accuracy over the last 20 trials. Total time to
reach criteria, total trials, total correct trials, total omits, average trial initiation latency,
average reward retrieval latency, anticipatory trials in the correct flanking hole, and
anticipatory trials in the incorrect flanking hole were recorded.
Stage 7: Reversal learning stage. Testing was nearly identical to that described
above in Stage 6, with the exception that the reinforcement contingencies associated with
the two holes were switched. Testing progressed in daily sessions until animals once
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again met the same learning criteria rule described above, and the same dependent
variables were collected. After reversal was completed, mice were slowly adjusted back
onto a free-feeding schedule.
Operant Conditioning – Delay discounting
As described above, mice were transitioned to a limited food access schedule,
once lickometer testing was completed. Once targeted reductions in body weights was
achieved, half of all the mice from each sex of each strain were randomly designated for
evaluation using a delay discounting procedure. Mice are removed from their home cage
and placed inside the operant box. A box test program evaluating the function of the
house light, white noise, five nose-poke apertures, two response levers and reward
delivery was conducted at the beginning of each testing day.
Each mouse was sequentially tested in a series of programs; mice transitioned
from program to program individually, as they met criterion performance (see below).
Mice underwent the following programs:
Stage 1: Box habituation. House light and white noise were active. No
reinforcements were provided. The session lasted 1-h.
Stage 2: Magazine training. Again, the house light and white noise were active for
the duration of the test, and 20-21µl Boost is dispensed every 30 seconds. The duration of
testing was 1-h.
Stage 3: Lever Press Training – FR1. Session onset was signaled by
illumination of the house light and activation of the white noise generator. On each trial,
one lever (left or right) is inserted to the chamber and actuation of the lever by the mouse
triggered delivery of 20-21 µl of Boost. Across trials, the lever that was inserted (left or

24

right) was pseudorandomly varied, such that each mouse actuated each lever a roughly
equal number of times. Each daily session ended after 1-h or after 60 reinforcements
were obtained.
Stage 4: Lever Press Training – FR3. In this stage of lever press training, a
procedure nearly identical to that described in Stage 3, above, was used. The only
difference was that 3 sequential responses on the inserted lever were required before the
reinforcer was delivered. The program ended after 1-h or after 60 rewards were obtained.
Stage 5: Trial Initiation Training. In this stage of training, a procedure nearly
identical to that described in Stage 4 was used. The only difference is that the mouse was
required to complete an observing response (nose poke response into the center hole
(aperture 3 of 5) on the opposite site of the chamber in order to trigger insertion of a
lever. Responses on that lever were still reinforced on an FR3 schedule. The program
ended after 1-h or after 60 rewards were obtained.
Stage 6: In this stage of training, a procedure nearly identical to that described in
Stage 5 was used. The only difference was that the program ended after 1.5 hours, or
after 80 rewards were obtained, whichever came first.
Stage 7: Side bias. Trials begin with both levers being presented, with a response
on either on a FR3 schedule resulting in a delivery of 8-9 µl of Boost. After a 10-s intertrial interval, both levers are again presented, but only a response on the other lever is
rewarded. A trial is only counted if the mouse successfully presses the alternate lever.
The program ends after 40 trials, or after 1.5 hours. The lever (right or left) on which
each trial is initiated is recorded, and the dominant lever is considered the biased lever
and is paired with the delayed lever.
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After completing training, all mice are placed on a randomized Latin square of 0s,
3s, 6s, and 9s. Three consecutive days of testing are done at each delay. Reward is
adjusted within trial, and delay is adjusted across sessions. Once the first Latin square is
completed, mice receive a two-day break, and they undergo a second Latin square.
Amount is measured for the immediate lever and the delayed lever and subtracted. The
reward amount for each lever is averaged over the last 30 trials, and those values are
averaged across the three days that delay was tested. These values are used to calculate a
k-value for each animal: the scaling factor, or how much the subjective value of the
reward is affected by the delay. The b-value is also recorded, which represents the
animal’s side bias, determined by dividing the average delayed amount by the average
immediate amount for the 0s delay.
Ethanol intake
After reintroduction to an unlimited diet for two weeks (no food restriction), all
reversal learning and delay discounting mice were again placed into Scurry lickometer
boxes (Model 80822S; Lafayette Instruments Inc.; Lafayette IN), with access to a 20%
ethanol and a tap water bottle (chow was also provided). Test sessions began one hour
into the dark phase and lasted for 12 hours. Bottles were weighed before and after
sessions for consumption analysis. Licks on both bottles were tracked for the whole
session. Bottle positions were counterbalanced between groups and alternated between
sessions. Mice were returned to the home-cage between sessions. All mice received 3
daily sessions.
Data Analysis
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Data for each variable was analyzed by an ANOVA using SPSS Statistics, with
number of licks for the lickometer task also analyzed using a linear mixed model. Data
was first examined using a body plot and outliers two standard deviations from the mean
were removed. Statistical significance was established to be a probability level of p<.05.
Independent variables were strain and sex. All ten strains were included in the analyses
for locomotor, reward intake, and ethanol intake, though the CC041/TauUncJ and
CC004/TauUncJ strains were not included in reversal learning or delay discounting due
to low subject numbers.
Heritability estimates were derived for each significant effect of strain using
effect size, which is an estimate of the variance accounted for by the independent variable
divided by the total amount of variance. Effect size is used to determine the magnitude of
the result, or how much variability is explained by the independent variable. By using
effect size for strain, the proportion of variance explained by strain, which translates to
what portion of the variability is heritable from the strain’s genotype. Despite the
structure of this study not being inter-generational, heritability is a justified measure
because of the nature of the founder strains. Each mouse within a strain is genetically
identical to one another, mimicking the heritable rigor of monozygotic twin studies
conducted in humans.
Results
To address strain level differences in body weight and/or in body weight change
in response to food restriction, an ANOVA was conducted on free-feeding weight
(grams) and percentage of free-feeding body weight at the start of testing and the average
at each stage of operant training: acquisition and reversal for reversal learning, and the
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first, second, third, and fourth delay periods for delay discounting. An interaction of sex
by strain (F[7,143]=4.89, p<.001), main effect of strain (F[7,143)=284.737, p<.001), and
main effect of sex (F[1,143]=145.744, p<.001) were unsurprisingly found for freefeeding weights due to the body mass variability of the founder strains. After food
deprivation began, no strain or sex differences in percentage body weight were found at
any point in operant experimentation for animals on reversal learning (Table 1) or delay
discounting (Table 2), demonstrating that we successfully altered body weights to the
same degree in each strain.
Locomotor Response to Novelty and Habituation
Total distance traveled in the open field chambers was assessed on days 1 and 2
of testing (Figure 1); these data were time-binned and were analyzed with a mixed model
ANOVA. An interaction was found between time and strain (F[9,135]=3.683, p<.001,
ηp2=.197), though not time and sex, or time and sex and strain (F<1.6, p>.121). Two
homogenous subsets emerged: strains with high ambulatory distance (C57BL/6J,
NOD/ShiLtJ, CAST/EiJ, PWK/PhJ, WSB/EiJ, CC004/TauUncJ) and strains with low
ambulatory distance (CC041/TauUncJ, NZO/H1LtJ, 129S1/SvImJ, and A/J). A main
effect was found for time bin (F[1,135]=135, p<.001, ηp2=.116), strain (F[9, 135]=46.56,
p<.001, ηp2=.756) and sex (F[1,135]=4.276, p<.05, ηp2=.031).
To evaluate the degree of habituation of the locomotor response occurring across
the two days, a difference score was calculated by subtracting distance traveled on D1
from distance traveled on D2 for each mouse (Figure 2, 3); these results were analyzed
using a two-way ANOVA. A main effect of strain was found (F[1,135]=3.683, p<.001,
ηp2=.197), though there was no main effect of sex nor an interaction between strain and
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sex (F<1.602, p>.121). PWK and CC041 mice were the only strains to exhibit an
increased ambulatory distance on the second day, evidence of sensitization rather than
habituation.
Palatable Food Consumption
We examined data from the 7 consecutive days of Boost and water consumption
conducted in the lickometer boxes. Considering only licks on the Boost spout, licks were
analyzed in total, as well as adjusted for body weight (Licks/Body weight). Examining
total licks, a linear mixed model demonstrated an interaction between strain and sex
(F[9,1022.019]=5.373, p<.001), a main effect of strain (F[9, 1021.943]=38.069, p<.001;
Figure 4), and a main effect of sex (F[1, 1031.775]=7.529, p<.01). When adjusted for
body weight, a linear mixed model found an interaction between strain and sex (F[9,
1006.71]=6.143, p<.001), a main effect of strain (F[9, 1006.71]=77.209, p<.001; Figure
5), and a trending main effect of sex (F[1, 1034.197]=3.647, p=.056). No interaction was
found for days by strain, days by sex, or days by strain by sex (F<.701, p>.938).
Similarly, water licks were analyzed in total, and adjusted for body weight. For total
licks, only a main effect of strain was found (F[9, 301.34]=4.144, p<.001; Figure 6).
PWK/PhJ mice made more water licks than all strains except for NZO/HlLtJ, CAST/EiJ,
and CC04/TauUncJ. Dividing total licks by body weight similarly revealed a main effect
of strain (F[9, 508.33]=5.833, p<.001; Figure 7). PWK/PhJ and CAST/EiJ mice had
significantly more licks adjusted for body weight than the other strains.
We next examined licking only on days 5-7 of testing to best estimate each
animal’s consummatory behavior at a point where licking behavior has stabilized. A
between subjects ANOVA on unadjusted Boost licks again showed a main effect of strain
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(F[9, 150]=12.464, p<.001, ηp2=.463; Figure 8, 9) and an interaction between strain and
sex (F[9, 150]=2.059, p<.05, ηp2=.125), but no main effect of sex (F[1, 150]=.29, p=.591,
ηp2=.002). CAST/EiJ mice had significantly more licks regardless of body weight than
all strains except for the CC004/TauUncJ and A/J. For Boost licks adjusted for body
weight, an interaction of strain by sex (F[9, 155]=1.97, p<.05, ηp2=.116) and a main
effect of strain (F[9, 155]=19.164, p<.0001, ηp2=.561; Figure 10, 11) was found.
CAST/EiJ mice lick significantly more than all other strains for their body weight. The
same was done for average water licks on the final three days. For total unadjusted water
licks, there was no main effect of strain or sex, or an interaction of strain by sex (Figure
12). For water licks adjusted for body weight, there was a trending main effect of strain
(F[9, 155]=1.92, p=.054, ηp2=.113; Figure 13), with no interaction of strain by sex.
A preference score was next calculated for each animal by dividing the number of
licks on the Boost spout by total licks (on the Boost and water spouts). This preference
score was again averaged over the final three days of consumption and analyzed using a
one-way ANOVA. No strain, sex, or strain by sex differences for preference was found
(p>.05 for all); however, this is almost certainly a “ceiling effect” due to very high
preference for Boost over water exhibited in all strains (Table 3).
Operant Conditioning – Reversal Learning
Reversal learning was analyzed examining the following at acquisition and
reversal: total trials, correct trials, omits, total time, trial initiation latency, pellet retrieval
time, average anticipatory correct responses, and average anticipatory incorrect
responses. A MANOVA was first performed, identifying multivariate main effects of
strain (F[72,250.89]=2.192, p<.001, ηp2=.31) and stage (F[8,40]=3.735, p<.01,
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ηp2=.428). A mixed model ANOVA was then run on the aforementioned variables. A
main effect of stage (acquisition or reversal) was found for total trials (F[1,47]=5.123,
p<.05, ηp2=.098; Figure 14), anticipatory correct responses (F[1,47]=4.173, p<.05,
ηp2=.082; Figure 15), and anticipatory incorrect responses (F[1,47]=13.103, p<.001,
ηp2=.218; Figure 16). A main effect of strain was found for omissions (F[9,47]=5.471,
p<.001, ηp2=.512), total time (F[9,47]=3.547 p<.001, ηp2=.404), trial initiation latency
(F[9,47]=4.714, p<.001, ηp2=.474), and average anticipatory incorrect responses
(F[9,47]=2.621, p<.05, ηp2=.334), with a trending effect for correct trials (F[9,47]=2.051,
p=.054, ηp2=.282). Neither main effects of sex nor an interaction of strain by sex were
found. A strain by stage interaction was only found for correct trials (F[9,47]=2.268,
p<.05, ηp2=.303). NZO/HlLtJ had the highest average of anticipatory incorrect responses,
significantly higher than the two lowest strains, CAST/EiJ and PWK/PhJ.
Operant Conditioning – Delay discounting
Variables k-value and b-value in delay discounting were analyzed with a between
subjects ANOVA. A multivariate main effect of strain was identified (F[18,122]=2.906,
p<.01, ηp2=.307), as well as a main effect of strain for k-value (F[18,122]=3.304, p<.01,
ηp2=.331; Figure 17, 18) and b-value (F[18,122]=3.966, p<.01, ηp2=.373). The
interaction between strain and b violated homogeneity of regression slopes and an
ANCOVA to isolate strain-dependent side bias was not conducted.
A Tukey post-hoc revealed 129S1/SvImJ mice as having the highest k-value,
significantly higher than all other strains. CAST/EiJ mice had the lowest, significantly
lower than 129S1/SvImJ and WSB/EiJ strains. 129S1/SvImJ mice additionally had the
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highest b-value, significantly higher than all but the WSB/EiJ mice, who had the second
highest.
Ethanol intake
A repeated measures ANOVA was run on each mouse’s total lick consumption
averaged over the three days of testing. A strain by sex interaction was found
(F[9,135]=3.195, p<.01, ηp2=.20; Figure 19, 20) as well as a main effect of strain
(F[9,135]=26.252, p<.001, ηp2=.673).
Correlations
A two-tailed bivariate Spearman’s correlation was conducted on overall strain
means to detect heritable relationships between phenotypes within the founders.
Ambulatory distance traveled on D1 of the open field task was positively correlated with
ambulatory distance traveled on D2 (rs=.952, p<.001; Table 4 cell 1B; Figure 21), and
average last three day Boost consumption was positively correlated with last three day
Boost preference (rs=.714, p<.05; Figure 22) as anticipated. Last three day Boost intake
was positively correlated with last three day water intake (rs=.786, p<.05; Figure 23),
though Boost preference was not correlated with water intake (rs=.357, p=.385). Last
three day Boost intake was negatively correlated with k-value (rs=-.786, p<.05; Figure
24).
Total trials to criteria at reversal was not correlated with total trials at acquisition
(rs=.452, p=.260; Table 4 cell 5F), though average anticipatory responding at reversal
was correlated with average anticipatory responding at acquisition for a Pearson
correlation (rs=.810, p<.05; Table 4 cell 8G). None of the impulsivity measures were
significantly correlated with each other: total trials to criteria at reversal and average
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incorrect anticipatory responses at reversal (rs=-.095, p=.823; Table 4 cell 6H); total trials
to criteria at reversal and k-value (rs=.381, p=.352; Table 4 cell 6I); average anticipatory
incorrect responses at reversal and k-value (rs=.571, p=.139; Table 4 cell 8I). K-value
was, however, was positively correlated with average anticipatory incorrect responses at
acquisition (rs=.810, p<.05; Figure 25; Table 4 cell 7I).
Ethanol intake did not correlate with total trials to criteria, anticipatory
responding, or k-value when collapsed for sex across strains. Analyzing each sex
separately, however, revealed a positive correlation between ethanol intake and total
trials at reversal for female mice (rs=.810, p<.05; Figure 22) though not male mice (rs=.19, p=.651). A correlation was also found for female mice between ethanol intake and
ambulatory activity on day 1 of locomotor response to novelty (rs=762, p<.05).
Correlation values are shown in Table 4, which reports Spearman’s Rho and
Pearson’s r.
Discussion
The goal of this study was to examine the heritability for addiction-related traits,
and further understand the relationship different aspects of impulsivity have with each
other and ethanol intake. Past studies have identified multiple dimensions of impulsivity
each with a unique relationship to drug taking (Evenden, 1999), and using genetic
reference population enables the examination of how these dimensions relate within
homogenous strains. This study additionally marks one of the first efforts to phenotype
the CC founder strains for these traits, and this study overall aims to provide a basis of
information that can be compared with other laboratories using the CC founders.
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Results show multiple heritable phenotypes emerging from the CC founder
strains. Strains showed high heritability for locomotor activity in response to novelty,
degree of habituation within the open field apparatus, reward sensitivity as measured by
total Boost licks, waiting impulsivity in reversal learning, impulsive choice in delay
discounting, and ethanol intake. Overall results demonstrate a genetic component of these
phenotypes, with varying degrees of heritability as determined by the effect size
associated with the strain level effect. Ambulatory distance in response to novelty and
reward intake exhibited the highest degree of heritability. Two of the three measures of
impulsivity (anticipatory incorrect trials and k-value) reached strain significance and each
exhibited robust heritability even among only the eight founder strains phenotyped so far.
Though total trials to criteria in acquisition and reversal did not exhibit statistically
significant heritability, it may be that the heritability of impulsive action is lower than can
be currently detected with the number of strains being used.
The results of this study thus far support those the theory proposed Evenden
(1998), and imply that these three dimensions of impulsivity have separate components.
We found no correlation between impulsive action, impulsive choice, and waiting
impulsivity, indicating that a strain that scored high on one dimension of impulsivity did
not necessarily score highly on another. These findings suggest one theory put forth by
Jentsch and colleagues (2014), suggesting that there is not one unitary “impulsivity” and
there exist different varieties each controlled by different mechanisms. While each of the
types of impulsivity tested do share some mechanistic similarities within the prefrontal
cortex, each does result in different cortical activation. Reversal learning, a test of action
inhibition, requires function of the orbitofrontal cortex and dorsomedial striatum for
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inhibitory control (Jentsch et al, 2014), also demonstrated by a MRI study in human
adults (Ghahremani et al., 2010). Conversely, tests of impulsive choice and waiting
impulsivity do not rely on the orbitofrontal cortex; impulsive choice is associated with
the lateral portions of the frontal cortex and the hippocampus, and waiting impulsivity is
associated with the ventromedial areas (Jentsch et al., 2014).
Dalley, Everitt, and Robbins (2011) suggested that anticipatory responding in the
5-CSRT and delay discounting paradigms have some overlap due to both tasks
necessitating action restraint, though delay discounting differs due to the variable of
relative reinforcing value. In the present study we found a correlation between average
anticipatory incorrect responses at acquisition and k-value, though not average
anticipatory incorrect responses at reversal. The lack of correlation at reversal indicates
that k-value is not related to cognitive inflexibility, though may be related to a measure of
action inhibition during the learning process. The acquisition stage of reversal is intended
to act as a learning control; all mice are permitted to undergo testing as long as necessary
until they meet criteria, to account for base strain differences in learning and memory. A
strain difference of incorrect anticipatory responses at acquisition may indicate a lack of
action restraint during training as well as a resilience to rule-learning, both of which
correlate with a strain’s relative value of a delayed reward. The lack of correlation of kvalue with anticipatory incorrect responses at reversal could demonstrate the subjects
modifying their behavior, or a smaller effect that cannot be detected with the current
number of strains.
It also must be examined how the reinforcing value of Boost played into the
results. Licks on the spout are a measure of palatability in subjects, which would appear
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to correlate with impulsive choice, though not impulsive action or waiting impulsivity.
We found a negative correlation between k-value and Boost licks in the reward
sensitivity task, which could indicate that strains more incentivized to consume Boost are
more willing to wait to receive it — finding Boost to be a higher value reward may be a
moderator of the devaluing that comes with a delay. Testing the strains in the lickometer
boxes provides essential information with regards to motivation and/or reward sensitivity.
Past research has suggested sensitivity to reward is a singular trait capable of predicting
motivation to seek out reinforcing stimuli (Davis & Fox, 2007), and presentation of food
and drug cues result in activation of similar regions as well as activate similar gene
expression programs (Kelley, Schiltz, & Landry, 2005). The fact that Boost licks are not
correlated with ethanol intake would suggest that either sensitivity to food reward and
ethanol reward are separate, or that another variable such as latency to consume may be a
more accurate measure of reward sensitivity. In human studies, over-consumption can be
a protective mechanism against drug dependence, as over-eating competes for the same
binding sites as drug use (Kleiner et al., 2004; Warren, Frost-Pineda, & Gold, 2005). This
has not been observed in animal models, and a negative correlation between Boost licks
and ethanol licks in this study was not observed.
Ultimately only one dimension of impulsivity was correlated with overnight
ethanol consumption, and the effect was sex-dependent. Only female mice demonstrated
a correlation between total trials to criteria in reversal learning with amount of licks on
the ethanol spout within the 12-hour consumption period. Waiting impulsivity and
impulsive choice did not correlate with ethanol licks in either sex. Impulsive action’s
relationship to ethanol intake may be reliant upon function of the orbitofrontal cortex.
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Lesions of the orbitofrontal cortex but not the medial prefrontal cortex result in slower
stop-signal reaction times (Jentsch et al., 2014), suggesting that the orbitofrontal cortex is
a fundamental component of action inhibition. Depletion of dopamine consistently results
in higher impulsivity in reversal learning (Jentsch et al., 2014) and D2-like receptor
stimulation increases inhibition and decreases impulsivity (Eagle et al., 2011), while
results are variable for delay discounting and the 5-CSRTT (Jentsch et al., 2014).
Similarly, individuals dependent upon alcohol, cocaine, heroin, and/or methamphetamine
consistently demonstrate lower D2 receptor availability, and a relationship has been
found in cocaine users between striatal D2 receptor density and OFC metabolic rates
(Volkow et al., 2001). Alcoholism specifically is associated with decreased D2 receptors
and mesolimbic dopamine transmission (Martinez et al., 2005) and it has been
hypothesized that the OFC is responsible for reward modulation in response to striatal
dopamine levels (Volkow et al., 2007). The relationship found in the present study may
indicate the OFC’s importance in modulating response inhibition, cognitive flexibility,
and sensitivity to ethanol, while not correlated with impulsive decision-making or
anticipatory responding. Sex differences specifically suggest that action inhibition is
modulated differently in males and females.
One of the limitations of this study is that correlations are being conducted with
only eight or ten strains. This relatively small sample size means that only correlations
with large effects are capable of being detected, such as female mice on impulsive action
and ethanol intake, or Boost licks and k-value. Until additional strains are added to this
study, the statistics being run are not powered to detect strain correlations with a low or
medium effect size. Therefore, ongoing work will accumulate phenotypes for an
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increasingly large number of the CC strains, providing stronger powered to detect small
to medium size effects.
For several phenotypes the strains exhibited clustering of scores. For example,
Boost licks over the seven days (Figure 4) showed homogenous subsets of CAST/EiJ;
NOD/ShiLtj, A/J, C57BL/6J, NZO/HILtJ, PWK/PhJ, and CC004/TauUncJ; and
129/SvlmJ, WSB/EiJ, and CC041/TauUncJ. This can also be seen in ambulatory distance
(Figure 1), anticipatory incorrect responses (Figure 16), and k-value (Figure 17). While
the founder strains were chosen due to their genetic diversity (Odet et al., 2015), this
grouping of scores is anticipated as it demonstrates that the clustered strains have the
same allele pairing on the gene for that phenotype. Considering base pairs are either A-T
or C-G, this pattern of results demonstrates that while the strains themselves are
genetically diverse, allelic similarity for a specific phenotype will result in clustering
rather than a continuous spectrum of responses.
The inclusion of the wild-derived strains (CAST/EiJ, WSB/EiJ, PWK/PhJ) gives
the CC more genetic diversity and ability to detect genetic correlations, though it
introduces a dichotomy with the non-wild-derived strains. The other five inbred strains
were selected from already existing inbred mouse lines. Bottlenecking has occurred since
mice were kept by collectors and researchers and bred selectively for the ease of capture
and handling, decreasing allelic diversity as they were inbred (Chesler, 2013).
Conversely, the wild-derived founders were inbred but not selected for traits of docility
or ease of handling. The end result is three strains that have heightened aggression in
comparison to the other five and likely other behavioral traits that haven’t been removed
through selective breeding. Considering impulsivity’s relationship with aggression has
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been well documented in humans (Gvion & Apter, 2011; Manuck et al., 2000) and mice
(Brunner & Hen, 1997; Lesch & Merschdorf, 2000), it must be considered that
inbreeding may have reduced impulsivity in the non-wild-derived strains.
Another consideration is that all mice were shipped during adolescence (PND 3549) and were individually-housed at the beginning of adulthood (PND 60). All efforts
were made to attenuate the effects of shipping by allowing animals to acclimate
untouched and group-housed for a week, and all strains underwent shipping. Single
housing was necessary due to the aggression of the CAST/EiJ, WSB/EiJ, and PWK/PhJ
strains, which become aggressive in both sexes during adulthood. As to not introduce the
variable of single- versus group-housing, the decision was made to single-house all
animals as late as possible, which was determined to be PND 60. One study isolated adult
male rats (PND 63-91) and later tested them on cocaine IVSA, running two separate
replicate studies to verify the reproducibility of results. The first group found that found
that isolated rats acquired cocaine IVSA faster, though both groups self-administered
similar levels by the fifth week of testing. The second group, however, had no
differences, suggesting that other contextual factors may moderate the social housing
effect (Bozarth, Murray, & Wise, 1987). Yet another study found that isolation-housing
for 12 days did not alter the ethanol consumption of adolescent rats, though it did
suppress consumption in adults (Doremus et al., 2006). It also must be taken into
consideration that certain strains may be more sensitive to the effects of isolation
housing, and the degree to which operant performance and ethanol intake is altered may
vary.
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A small amount of caffeine is present in the Boost reinforcer and may exert an
effect, particularly if one or more strains was exceptionally sensitive. Chocolate Boost
contains .62 mg of caffeine in one fluid ounce (Caffeine Informer). The maximum
amount of caffeine a mouse could receive on average per day was calculated. Each
reward delivery is approximately 20 µl, or .00068 fluid ounces, resulting in mice
receiving .00418 mg caffeine per reinforcer. The maximum reinforcers a mouse received
on average was 80 in delay discounting, with less rewards being received in reversal
learning. Thus, a mouse could possibly receive at maximum of .3344 mg of caffeine per
day. This was converted into a mg/kg dose for a low weight animal (12g) and a high
weight animal (40g). Respectively the daily dose was calculated to be 10 mg/kg and 3
mg/kg (PO). A bolus dose of 15 mg/kg i.p. caffeine is described as being a moderate dose
(Hnasko, Sotak, & Palmiter, 2005), and 1.5 mg/kg i.p. doses were found to be enough to
produce conditioned place preference in mice (Patkina & Zvartau, 1998). Past studies
have shown that .5-16 mg/kg i.p. dose of caffeine increases locomotor activity in mice
(Kayir & Uzbay, 2004), and i.p. doses at 5mg/kg-15mg/kg increase wakefulness (Huang
et al., 2005). Route of administration additionally plays a factor: oral consumption of
caffeine decreased the amount of cocaine later self-administered, while 3 mg/kg i.p.
injections increased it despite similar metabolite levels (Kuzmin et al., 2000). This
information indicates that mice in the present study were receiving variable levels of
caffeine that depended on weight and number of reinforcers received, though this was at
maximum a low-moderate dose.
Altogether, the present study marks one of the preliminary attempts to phenotype
the CC founder strains for ambulatory activity, reward sensitivity, three types of
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impulsivity, and ethanol intake. Heritability for these traits has been identified, as well as
a correlation between impulsive action and ethanol intake. Importantly none of the
impulsivity measures were found to be correlated with one another, and the fact only one
was related to ethanol intake indicates a potential sex-dependent effect of the
orbitofrontal area of the cortex. Future research will include the CC strains, enabling
correlations with low and medium effect sizes to be conducted, and eventually the
identification of gene candidates within the striatum.
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Tables
Mouse ID
NOD/ShiLtJ F
NOD/ShiLtJ M
129S1/SvImJ F
129S1/SvImJ M

Free-feed Start Acquisition Reversal
23.2g 85.3%
85%
90.8%
29.5g 88.3%
83.5%
85%
21.7g
91%
89.3%
88.8%
25.3g 89.8%
88.6%
85.8%

A/J F

18.8g 89.6%

85.4%

85.2%

A/J M

23.5g 89.5%

83.0%

83.3%

C57BL/6J F

20.4g 89.3%

88%

87.8%

C57BL/6J M

26.3g 85.2%

85.4%

85.8%

NZO/H1LtJ F

36.3g

93%

86%

83.5%

NZO/H1LtJ M
CAST/EiJ F

41.4g 88.5%
13.1g 88.6%

89%
86.2%

86.5%
86.8%

CAST/EiJ M

16.0g

92%

88%

86%

WSB/EiJ F

16.9g

90%

84.3%

87%

WSB/EiJ M

17.5g

95%

84.5%

86.5%

PWK/PhJ F

15.4g 84.5%

86%

88%

PWK/PhJ M

17.8g 84.8%

86.4%

83.6%

Table 1. Free-feeding body weights and percentage of free-feeding weight for mice that
underwent reversal learning, averaged by strain and sex. There were no differences
between the strains in percentage body weight.
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Mouse ID
NOD/ShiLtJ
F
NOD/ShiLtJ
M
129S1/SvImJ
F
129S1/SvImJ
M
A/J F
A/J M
C57BL/6J F
C57BL/6J M
NZO/H1LtJ
F
NZO/H1LtJ
M
CAST/EiJ F
CAST/EiJ M
WSB/EiJ F
WSB/EiJ M
PWK/PhJ F
PWK/PhJ M

Free-feed

Start

1st delay

2nd delay

3rd delay

4th delay

21.8g

90.4%

89%

90.2%

88.8%

88.2%

27.5g

84%

86.3%

88.8%

86.3%

83.8%

20.4g

90.2%

87.8%

88.8%

86.6%

86.6%

23.6g
20.4g
22.4g
20.5g
28.4g

91%
89%
88.2%
92%
86%

87.3%
86.8%
84.2%
88%
84.5%

88.3%
84.8%
86.6%
93%
86.5%

86%
83.8%
89.2%
88.6%
86.5%

87%
83.3%
86.4%
88%
85%

36.2g

90.3%

83.7%

85.3%

83%

82.7%

41.5g
13.5g
16.4g
17.4g
18.4g
15.1g
17.3g

89%
87.8%
88%
90.3%
95%
89.2%
89.5%

85.8%
87.8%
85.8%
84.7%
88.3%
85%
87.8%

84.3%
86.5%
86.3%
92%
89.8%
88.8%
85.8%

83.2%
89.3%
86.8%
88%
85.8%
85%
86.5%

83.5%
87.3%
84.5%
92%
89%
87.8%
86.8%

Table 2. Free-feeding body weights and percentage of free-feeding weight for mice that
underwent delay discounting, averaged by strain and sex. There were no differences
between the strains in percentage body weight.
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Mouse ID

Mean

SD

NOD/ShiLtJ F

0.95

0.07

NOD/ShiLtJ M

0.9

0.13

129S1/SvImJ F

0.74

0.26

129S1/SvImJ M

0.94

0.11

A/J F

0.86

0.11

A/J M

0.9

0.15

C57BL/6J F

0.93

0.04

C57BL/6J M

0.91

0.12

NZO/H1LtJ F

0.91

0.08

NZO/H1LtJ M

0.9

0.06

CAST/EiJ F

0.93

0.14

CAST/EiJ M

0.91

0.09

WSB/EiJ F

0.83

0.18

WSB/EiJ M

0.85

0.08

PWK/PhJ F

0.87

0.14

PWK/PhJ M

0.91

0.08

Table 3. Means and standard deviations of Boost licks divided by total licks, averaged
over the last three days of consumption.
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A
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

r=.982
p<.001
r=-.582
p=.130
r=.117
p=.675
r=.021
p=.961
r=-.314
p=.449
r=-.816
p=.012
r=-.797
p=.018
r=-.406
p=.318
r=.406
p=.318

B

C

D

E

rs=.952
p<.001

rs=-.527
p=.117
rs=-.333
p=.347

rs=.115
p=.751
rs=.200
p=.580
rs=-.127
p=.726

rs=-.055
p=.881
rs=.042
p=.907
rs=-.091
p=.803
rs=.333
p=.347

r=-.416
p=.305
r=.205
p=.626
r=.021
p=.961
r=-.266
p=.525
r=-.819
p=.013
r=-.850
p=.007
r=-.406
p=.318
r=.513
p=.194

r=-.030
p=.943
r=-.009
p=.983
r=-.365
p=.374
r=.445
p=.269
r=.172
p=.683
r=.206
p=.624
r=.250
p=.550

r=-.057
p=.893
r=.065
p=.878
r=-.510
p=.197
r=-.508
p=.119
r=-.629
p=.095
r=.047
p=.991

r=.459
p=.252
r=-.173
p=.683
r=-.289
p=.487
r=.536
p=.171
r=-.094
p=.824

F
rs=-.285
p=.425
rs=-.297
p=.405
rs=.442
p=.20
rs=-.127
p=.726
rs=.139
p=.701

r=.199
p=.636
r=-.079
p=.852
r=.219
p=.602
r=.144
p=.734

G
rs=-.588
p=.074
rs=-.552
p=.098
rs=.333
p=.347
rs=-.455
p=.187
rs=.018
p=.960
rs=.055
p=.881

r=.823
p=.012
r=.448
p=.266
r=-.498
p=.209

H

I

J

rs=-.539
p=.108
rs=-.661
p=.038
rs=.224
p=.533
rs=-.588
p=.074
rs=-.661
p=.038
rs=.103
p=.777
rs=.491
p=.150

rs=-.236
p=.511
rs=-.248
p=.489
rs=.03
p=.934
rs=-.236
p=.511
rs=.382
p=.276
rs=-.607
p=.855
rs=.721
p=.019
rs=.164
p=.651

rs=.552
p=.098
rs=.418
p=.229
rs=-.261
p=.467
rs=.273
p=.446
rs=-.709
p=.829
rs=.055
p=.881
rs=-.297
p=.405
rs=-.188
p=.603
rs=.152
p=.676

r=.285
p=.494
r=-.443
p=.272

Table 4. Correlation table for strains collapsed by sex. A priori correlations are
highlighted in green and significant a priori correlations are highlighted in yellow.
Spearman correlations are reported on the upper right and Pearson correlations are
reported on the lower left. The variables are as follows:
1/A. Ambulatory distance on D1 of locomotor
2/B. Ambulatory distance on D2 of locomotor
3/C. D2-D1 ambulatory distance of locomotor
4/D. Boost licks averaged over the final 3 days adjusted for body
weight
5/E. Total trials to criteria in acquisition of reversal learning
6/F. Total trials to criteria in reversal of reversal learning
7/G. Average anticipatory incorrect responses in acquisition
8/H. Average anticipatory incorrect responses in reversal
9/I. k-value
10/J. Ethanol licks averaged over 3 days of consumption
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r=-.289
p=.448
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Figure 1. Ambulatory distance calculated by total centimeters on day 1 and day 2 in the
open field chamber.
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Figure 2. The total centimeter difference between day 2 and day 1 in the open field
chamber.
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Figure 3. The total centimeter difference between day 2 and day 1 in the open field
chamber displayed as a box plot.
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Boost Intake
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Figure 4. Average total number of Boost licks for each strain daily across seven
consecutive days of testing.
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Figure 5. Average total number of Boost licks adjusted for body weight (Licks/g body
weight) for each strain daily across seven consecutive days of testing.
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Figure 6. Average total number of water licks for each strain daily across seven
consecutive days of testing.
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Figure 7. Average total number of water licks adjusted for body weight (Licks/g body
weight) for each strain daily across seven consecutive days of testing.
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Figure 8. Average of the Boost licks on the last three days of testing (D5-D7) across
strains.
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Figure 9. Average of the Boost licks on the last three days of testing (D5-D7) across
strains displayed as a box plot.
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Figure 10. Average of the Boost licks on the last three days of testing (D5-D7) across
strains, adjusted for body weight (licks/g body weight).
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Figure 11. Average of the Boost licks on the last three days of testing (D5-D7) across
strains, adjusted for body weight (licks/g body weight) displayed as a box plot.
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Figure 12. Average of the water licks on the last three days of testing (D5-D7) across
strains.
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Figure 13. Average of the water licks on the last three days of testing (D5-D7) across
strains, adjusted for body weight (licks/g body weight).
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Figure 14. Average total trials in acquisition and reversal stages across strain. An
increase from acquisition to reversal demonstrates cognitive inflexibility and impulsive
action.
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Figure 15. Average anticipatory correct response per trial (total correct anticipatory
responses/total trials) in acquisition and reversal stages across strain.
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Figure 16. Average anticipatory incorrect response per trial (total correct anticipatory
responses/total trials) in acquisition and reversal stages across strain.
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Figure 17. Average k-value in delay discounting across strain.
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Figure 18. Average k-value in delay discounting across strain displayed as a box plot.
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Figure 19. Average ethanol licks across the 3 days of testing, adjusted for body weight.
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Figure 20. Averaged ethanol licks over 12 hours of testing, adjusted for body weight.
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Figure 21. Positive correlation between ambulatory distance on D1 of locomotor testing
and D2 of locomotor testing.
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Figure 22. Positing correlation between Boost licks adjusted for body weight averaged
over the last three days of testing and Boost preference averaged over last three days of
testing.

67

Water licks

20
15
10
5
0

0

100

200

300

400

Boost licks
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the last three days of testing.
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averaged across the final three days of consumption.
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